Pipeline and Clinical Trials
Vetigenics has a promising pipeline of products aimed at addressing cancer and other chronic pet diseases. With a focus on R&D and a commitment to developing novel approaches, Vetigenics is well-positioned to address a range of challenges facing the pet health industry.
Explore Details About our Clinical Trials:
For CTLA4 (VGS-001) trial in canine oral melanoma, visit:
For PD-1 (VGS-002) trial in canine urothelial carcinoma, visit:
Ethos Veterinary Health – Actively Recruiting